Who are Bilayer Therapeutics's investors?

Bilayer Therapeutics's investors include Kendall Capital Partners.

How much funding has Bilayer Therapeutics raised?

Bilayer Therapeutics has disclosed $2.3M raised across 2 rounds.

Bilayer Therapeutics is headquartered in Cambridge, US.

Cambridge, US · Founded 2020 · Delaware corporation · 1 known investors

Paths you didn't know you had: your email and LinkedIn already hold routes to the Bilayer Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Thomas A. ColletExecutive

Carlo Traverso GiovanniNamed on SEC filing

Robert LangerBoard directorScientific Advisory Committee Member at Polaris Partners

Joshua KorzenikBoard director

Form D private placements

$2.3M disclosed across 2 rounds · 2021–2023

▶$300KraisedAug 2023 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

▶$2MraisedApr 2021 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Who are Bilayer Therapeutics's investors?: Bilayer Therapeutics's investors include Kendall Capital Partners.
How much funding has Bilayer Therapeutics raised?: Bilayer Therapeutics has disclosed $2.3M raised across 2 rounds.
Where is Bilayer Therapeutics headquartered?: Bilayer Therapeutics is headquartered in Cambridge, US.